HUL challenges Rs 962-crore tax demand for Rs 3,000-crore GSK deal

Hindustan Unilever Limited (HUL) has filed an appeal with the Commissioner of Income Tax to challenge the Rs 962 crore tax demand related to its acquisition of the ‘Horlicks’ brand from GlaxoSmithKline (GSK).

By  Storyboard18Oct 16, 2024 3:03 PM
HUL challenges Rs 962-crore tax demand for Rs 3,000-crore GSK deal
HUL completed the merger of GSK Consumer Healthcare with itself, and acquired Horlicks brand for India from GSK for Rs 3,045 crore, in April 2020.(Image source: Moneycontrol)

Within two months of receiving a tax notice of Rs 962.75 crore related to its acquisition of the ‘Horlicks’ brand from GlaxoSmithKline (GSK), Hindustan Unilever Limited (HUL) has filed an appeal with the Commissioner of Income Tax.

In August, HUL announced of received a tax notice of Rs 962.75 crore, including an interest of Rs 329.33 crore.

In its exchange filing then, the FMCG firm announced that the demand has been issued for the non-deduction of tax deducted at source for a remittance of Rs 3,045 crore for the payment towards the purchase of India Health Food Drink (HFD) Intellectual Property Rights (IPR) from GSK Group entities.

The company now has challenged the tax demand and has also applied for a stay of demand and requested a pause on penalty proceedings.

In its recent exchange filings, dated September 24, HUL mentioned initiating steps to invoke indemnification from GSK for the tax notices, stating it does not foresee any material financial implications at this stage.

HUL completed the merger of GSK Consumer Healthcare with itself, and acquired Horlicks brand for India from GSK for Rs 3,045 crore, in April 2020. With the same, HUL took ownership of the brands including Boost, Maltova and Viva.

It is to be noted that the tax department issued HUL a notice on October 7, 2022, seeking capital gains tax on the transaction.

Recently, on September 23, the Bombay High Court dismissed a writ petition filed by HUL seeking protection from these tax notices, on account of the company having statutory remedy of an appeal against the assessment order.

The HUL-GSK case mirrors the whole dispute and grey area in the Indian tax law on whether the sale of intellectual property (IP) should be taxed in the country where the IP is held or in the country where it is used.


Tags
First Published on Oct 16, 2024 3:03 PM

More from Storyboard18

How it Works

Digital drives future, TV still steers wheel for auto brands: TAM

Digital drives future, TV still steers wheel for auto brands: TAM

How it Works

Eureka Forbes raises ad spend by 25% to Rs 259.5 cr in FY25

Eureka Forbes raises ad spend by 25% to Rs 259.5 cr in FY25

How it Works

India may discourage film shooting, destination weddings in Turkiye, Azerbaijan amid Indo-Pak tensions

India may discourage film shooting, destination weddings in Turkiye, Azerbaijan amid Indo-Pak tensions

How it Works

Indians boycott travel to Turkey, Azerbaijan amid Indo-Pak tensions, cancellations surge 250% on MakeMyTrip

Indians boycott travel to Turkey, Azerbaijan amid Indo-Pak tensions, cancellations surge 250% on MakeMyTrip

How it Works

'India doing very well, increase manufacturing in America': Donald Trump tells Apple CEO Tim Cook

'India doing very well, increase manufacturing in America': Donald Trump tells Apple CEO Tim Cook

How it Works

Govt cracks down on ecomm platforms over sale of Pakistani flags; CCPA issues notices

Govt cracks down on ecomm platforms over sale of Pakistani flags; CCPA issues notices

How it Works

TCS ranked among Top 50 most valuable global brands by Kantar BrandZ 2025

TCS ranked among Top 50 most valuable global brands by Kantar BrandZ 2025

How it Works

Indian film bodies declare boycott of Turkey over Pro-Pakistan stance amid rising tensions

Indian film bodies declare boycott of Turkey over Pro-Pakistan stance amid rising tensions